TY - JOUR
T1 - What's new in molecular genetic pathology 2021
T2 - Solid tumors and NGS panel selection
AU - Chen, Guoli
AU - Tsang, Patricia C.
N1 - Publisher Copyright:
© 2021 Seoul National University. All rights reserved.
PY - 2021/11
Y1 - 2021/11
N2 - The linchpin of precision medicine is molecular genetic and genomic testing. Molecular biomarkers are important for establishing precise diagnoses and for predicting therapeutic responses that enable cancer patients to receive personalized and targeted treatment. Below are highlights of the current considerations in next generation sequencing (NGS) panel selection, and in molecular testing of solid tumors of the lung, digestive system, thyroid and soft tissue.
AB - The linchpin of precision medicine is molecular genetic and genomic testing. Molecular biomarkers are important for establishing precise diagnoses and for predicting therapeutic responses that enable cancer patients to receive personalized and targeted treatment. Below are highlights of the current considerations in next generation sequencing (NGS) panel selection, and in molecular testing of solid tumors of the lung, digestive system, thyroid and soft tissue.
UR - http://www.scopus.com/inward/record.url?scp=85120619989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120619989&partnerID=8YFLogxK
U2 - 10.4132/jptm.2021.09.01
DO - 10.4132/jptm.2021.09.01
M3 - Article
AN - SCOPUS:85120619989
SN - 2383-7837
VL - 55
SP - 421
EP - 422
JO - Journal of Pathology and Translational Medicine
JF - Journal of Pathology and Translational Medicine
IS - 6
ER -